Skip to content

Insider · CIK 0001566094

Jeffrey B. Mirviss

officer

Files at BSX (BOSTON SCIENTIFIC CORP). First filing Jan 3, 2025, latest Feb 25, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $2.9M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BSX: BOSTON SCIENTIFIC CORP

BSXOct 9, 2026 · close 42.73

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
37Weak
BSXsell 710b5-1
BOSTON SCIENTIFIC CORP
$767k
7,363 shares
-22%-
21Weak
BSXsell 710b5-1
BOSTON SCIENTIFIC CORP
$159k
1,510 shares
-4%-
45Moderate
BSXsell 710b5-1
BOSTON SCIENTIFIC CORP
$1.4M
13,022 shares
-31%-
20Weak
BSXsell 310b5-1
BOSTON SCIENTIFIC CORP
$643k
7,152 shares
-20%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 24, 2025BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-4,675$104.25$487k28,454Feb 25, 2025
Feb 25, 2025BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-2,688$104.00$280k25,766Feb 25, 2025
Feb 19, 2025BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-1,510$105.35$159k33,129Feb 19, 2025
Feb 14, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock
+2,776$0.00$032,477Feb 18, 2025
Feb 14, 2025BSX
BOSTON SCIENTIFIC CORP
FTax withholding
Common Stock
-1,266$106.11$134k31,211Feb 18, 2025
Feb 16, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock
+2,970$0.00$034,181Feb 18, 2025
Feb 16, 2025BSX
BOSTON SCIENTIFIC CORP
FTax withholding
Common Stock
-1,355$106.11$144k32,826Feb 18, 2025
Feb 17, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock
+3,334$0.00$036,160Feb 18, 2025
Feb 17, 2025BSX
BOSTON SCIENTIFIC CORP
FTax withholding
Common Stock
-1,521$106.11$161k34,639Feb 18, 2025
Feb 13, 2025BSX
BOSTON SCIENTIFIC CORP
AGrant or award
Restricted Stock Unitsderivative
+5,181$0.00$05,181Feb 18, 2025
Feb 13, 2025BSX
BOSTON SCIENTIFIC CORP
AGrant or award
Stock Option (Right to Buy)derivative
+13,334$0.00$013,334Feb 18, 2025
Feb 14, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Restricted Stock Unitsderivative
-2,776$0.00$05,552Feb 18, 2025
Feb 16, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Restricted Stock Unitsderivative
-2,970$0.00$02,970Feb 18, 2025
Feb 17, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Restricted Stock Unitsderivative
-3,334$0.00$00Feb 18, 2025
Feb 12, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock
+2,115$0.00$030,569Feb 14, 2025
Feb 12, 2025BSX
BOSTON SCIENTIFIC CORP
FTax withholding
Common Stock
-868$105.77$92k29,701Feb 14, 2025
Feb 12, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Restricted Stock Unitsderivative
-2,115$0.00$06,347Feb 14, 2025
Feb 11, 2025BSX
BOSTON SCIENTIFIC CORP
AGrant or award
Common Stock10b5-1
+23,760$0.00$052,214Feb 13, 2025
Feb 11, 2025BSX
BOSTON SCIENTIFIC CORP
FTax withholding
Common Stock10b5-1
-10,738$105.98$1.1M41,476Feb 13, 2025
Feb 12, 2025BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-13,022$105.06$1.4M28,454Feb 13, 2025
Jan 1, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Common Stock10b5-1
+10,430$0.00$038,884Jan 3, 2025
Jan 1, 2025BSX
BOSTON SCIENTIFIC CORP
FTax withholding
Common Stock10b5-1
-3,278$89.32$293k35,606Jan 3, 2025
Jan 3, 2025BSX
BOSTON SCIENTIFIC CORP
SOpen-market sale
Common Stock10b5-1
-7,152$89.86$643k28,454Jan 3, 2025
Jan 1, 2025BSX
BOSTON SCIENTIFIC CORP
MOption exercise
Performance Share Unitsderivative10b5-1
-10,430$0.00$00Jan 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey B. Mirviss: insider trades and track record | InsiderTell